Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Brain scans reveal how anti-vaping ads may curb e-cigarette use in young black adults

NCT ID NCT05829863

Knowledge-focused Sponsor: University of Georgia Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study used brain scans and follow-up surveys to understand how anti-vaping public service announcements influence young African American vapers. 24 participants watched the ads during an fMRI scan and reported their vaping and smoking habits over the next month. The goal is to learn which brain responses predict whether someone will cut back on vaping.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
educational message exposure
What this could lead to
If successful, this could help design more effective anti-vaping ads for young African American vapers.
What could go wrong
This is a small, completed observational study with only 24 participants, so results may not apply broadly. It does not test a treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

24 people

The number who actually took part.

Started

May 2023

Finished

May 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 29 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 18-29 years old * used e-cigarettes or other vaping devices at least once during the past 30 days * did not smoke or use cigarettes during the past 30 days * self-identify as African American * magnetic resonance imaging (MRI) compatible and safe Exclusion Criteria: * younger than 18 years old, or older than 29 years old * did not use e-cigarettes or other vaping devices during the past 30 days * smoked or use cigarettes at least once during the past 30 days * history of a major neurological, psychiatric, or medical disorder * MRI contraindications

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Message exposure are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Message exposure

Contacts and locations

Locations

  • UGA Bio-imaging Research Center

    Athens, Georgia, 30602, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.